Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Laurus Labs has informed about the details of Analyst/ Institutional Investor meeting to be conducted on November 19, 2020 with Ambit's Health care Conclave. Further details as enclosed. Date of the aforesaid meetings are subject to change due to exigencies on the part of Investors/ Company. No Unpublished Price Sensitive Information will be shared during the meetings.
The above information is a part of company’s filings submitted to BSE.
